Preclinical study of adenoviral p53 gene therapy for esophageal cancer

Surgery Today

Volumn 31, Issue 7, 2001, Pages 597-604

  Shimada, Hideaki ^a   Shimizu, Takanori ^a   Ochiai, Takenori ^a   Liu, Ting Ling ^a   Sashiyama, Hiroshi ^a   Nakamura, Atsushi ^b   Matsubara, Hisahiro ^a   Gunji, Yoshio ^a   Kobayashi, Susumu ^a   Tagawa, Masatoshi ^c   Sakiyama, Shigeru ^c   Hiwasa, Takaki ^d  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Aventis Pharma Ltd   (Japan)

^c CHIBA CANCER CENTER   (Japan)

^d CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Esophageal cancer; Gene therapy; p21; p53

Indexed keywords

PROTEIN P21; PROTEIN P53; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION; GENE INDUCTION; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOUSE; NICK END LABELING; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ADENOVIRUSES, HUMAN; ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GENE THERAPY; GENES, P53; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; RECOMBINATION, GENETIC; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034945162     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950170093     Document Type: Article

References (37)

1. Recent advances of treatment of cancer of the esophagus
2. First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, and N, M0) squamous cell carcinoma of the thoracic esophagus: Final report on 163 consecutive patients with 5-year follow-up
3. Relationship between 5-fluoro-2′-deoxyuridylate, 2′-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomas
4. Novel mechanisms of resistance to 5-fluorouracil in human colon cancer (HCT-8) subline following exposure to two different clinically relevant dose schedules
5. New biological agents come to bat for cancer therapy
6. p53 is required for radiation-induced apoptosis in mouse thymocytes
7. The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents
8. Association of p53 gene mutation with decreased chemo sensitivity in human malignant gliomas
9. Frequent mutation of the p53 gene in human esophageal cancer
10. p53 protein accumulation during multistage human esophageal carcinogene mutation and sis
11. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas
12. The p53 mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stage of curability
13. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer
14. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
15. Expression of wild-type p53 gene confers increased sensitivity to radiation and chemotherapeutic agents in human esophageal carcinoma
16. Establishment of a parathyroid hormone-like factor-producing esophageal carcinoma cell line (EC-GI)
17. A case of esophageal carcinoma metastatic to the mandible and characterization of two cell lines (T.T. and T.Tn.)
18. Safety evaluation of Ad5CMV-p53 in vitro and in vivo
19. Manipulation of adenovirus vectors
20. Gene transfer into experimental brain tumors mediated by adenovirus. Herpes simplex virus, and retrovirus
21. DNA strand breaks occuring in apoptosis: Their early detection by deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors
22. Nuclear localization of procathepsin L/MEP in ras-transformed mouse fibroblasts
23. WAF1, a potential mediator of p53 tumor suppression
24. p53 tumor suppressor gene therapy for cancer
25. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo
26. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts
27. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer
28. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer
29. Effects of ectopic overexpression of p21(WAF1/CIP1) on aneuploidy and the malignant phenotype of human brain tumor cells
30. Expression of p53 and p21WAF1/CIP1 proteins in gastric and esophageal cancers: Comparison with mutations of the p53 gene
31. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53
32. The p21 CDK-interacting protein Cip 1 is a potent inhibitor of G1 cyclin-dependent kinases
33. Immune response to recombinant adenovirus in humans: Capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes
34. Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy
35. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene
36. Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemo-therapeutic agent
37. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation